Sodium Sulfacetamide 10% wash (sodium sulfacetamide) NDC 83720-543

NDC codes

FDA NDC Directory

Product NDC (as listed)83720-543Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83720-0543Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83720-543-16	83720054316	473 mL in 1 BOTTLE (83720-543-16)Marketed from Nov 14, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Sulfacetamide 10% wash
Generic name (nonproprietary): sodium sulfacetamide
Active ingredients: Sulfacetamide sodium — 100 mg/mL
Dosage form: Liquid
Route: Topical
Labeler: Oncor Pharmaceuticals
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Nov 14, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 83720-543_4da2c1a0-7b73-52c4-e063-6294a90aa57bSPL ID 4da2c1a0-7b73-52c4-e063-6294a90aa57bSPL set ID 448e383a-2dbe-411f-a8a7-c83156e8a503RxCUI 1006107UNII 4NRT660KJQUPC 0383720543164
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483720054316 followed by a unit qualifier and the quantity

Package 83720-0543-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 22, 2026.

Indications (excerpt from the label)

INDICATIONS Sodium Sulfacetamide is intended for topical application in the following scaling dermatoses: Seborrheic dermatitis and seborrhea sicca (dandruff). It also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)